Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist - Top-Institutions - MDSpire

Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist

Board-certified neurologist Zack Z. Ramilevich, M.D., has joined Marcus Neuroscience Institute, part of Baptist Health, as a general neurologist.

  • By

  • March 26, 2026

  • 2 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neuroscience
    • Stroke
    • Epilepsy
    • Neurodegenerative Diseases

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neuroscience
    • Stroke
    • Multiple Sclerosis
    • Epilepsy

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Neuroscience
    • Stroke
    • Neurodegenerative Diseases
    • Epilepsy

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Stroke
    • Epilepsy
    • Neurodegenerative Diseases

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neuroscience
    • Stroke
    • Multiple Sclerosis
    • Epilepsy

Original Source(s)

Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist

  • by

  • March 26, 2026

Related Content

Ictal gamma increase shows preferential localization to seizure onset contacts in stereoelectroencephalography

Prognostic value of systemic inflammation response index in successfully recanalized acute large vessel occlusion stroke patients: a retrospective study

The effects of transcranial direct current stimulation on global cognitive function, visuospatial function, and executive function in patients with mild cognitive impairment and Alzheimer’s disease: a meta-analysis